TRPM8 and prostate carcinoma: However, most lines of evidence, including the present study, strongly suggest an anti–migratory role of TRPM8, shedding light on the possibility of using TRPM8 agonists, such as PSA, WS12, and icilin, to counteract the metastasis of prostate cancer [17,21].